We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$6.76B
(-2.7%)
Cap. Flow
-$7.92B
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
3,301
New
48
Increased
1,481
Reduced
1,530
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$508M |
| 2 |
L3Harris
LHX
|
+$420M |
| 3 |
Salesforce
CRM
|
+$251M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$225M |
| 5 |
Texas Instruments
TXN
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
PayPal
PYPL
|
+$367M |
| 4 |
Qualcomm
QCOM
|
+$306M |
| 5 |
WP
Worldpay, Inc.
WP
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 12.29% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
2476
DELISTED
Cymabay Therapeutics
CBAY
| $1.7M | ﹤0.01% |
332,753
-11,293
| -3% | -$68.4K |
|
|
CCXI
2477
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.7M | ﹤0.01% |
250,960
-152,319
| -38% | -$1.14M |
|
|
HONE
2478
DELISTED
HarborOne Bancorp
HONE
| $1.7M | ﹤0.01% |
168,291
+63,885
| +61% | +$660K |
|
2479
Q32 Bio
QTTB
$464M
| $1.69M | ﹤0.01% |
5,183
+134
| +3% | +$45.5K |
|
2480
Turning Point Brands
TPB
$1.74B
| $1.68M | ﹤0.01% |
72,779
-22,789
| -24% | -$868K |
|
|
CAMP
2481
DELISTED
CalAmp Corp.
CAMP
| $1.68M | ﹤0.01% |
6,334
-183
| -3% | -$45.1K |
|
2482
Arrow Financial
AROW
$652M
| $1.67M | ﹤0.01% |
56,421
-2,210
| -4% | -$63.7K |
|
2483
TG Therapeutics
TGTX
$7.62B
| $1.67M | ﹤0.01% |
298,008
+1,822
| +0.6% | +$12.7K |
|
|
IMGN
2484
DELISTED
Immunogen Inc
IMGN
| $1.67M | ﹤0.01% |
688,945
-16,606
| -2% | -$44.1K |
|
2485
Precigen
PGEN
$2.59B
| $1.67M | ﹤0.01% |
291,429
-20,921
| -7% | -$142K |
|
|
VRTV
2486
DELISTED
VERITIV CORPORATION
VRTV
| $1.67M | ﹤0.01% |
92,191
+10,036
| +12% | +$173K |
|
2487
Antero Resources
AR
$10.7B
| $1.66M | ﹤0.01% |
550,316
-3,018,578
| -85% | -$12.3M |
|
2488
Constellium
CSTM
$3.99B
| $1.65M | ﹤0.01% |
130,114
| – | – |
|
2489
Wave Life Sciences
WVE
$1.2B
| $1.65M | ﹤0.01% |
80,282
+2,557
| +3% | +$58.6K |
|
2490
nLIGHT
LASR
$3.17B
| $1.65M | ﹤0.01% |
105,175
+2,033
| +2% | +$31.5K |
|
2491
Energy Transfer Partners
ET
$69.3B
| $1.64M | ﹤0.01% |
125,021
-782,499
| -86% | -$10.9M |
|
|
CLVS
2492
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.63M | ﹤0.01% |
414,747
+44,037
| +12% | +$356K |
|
|
ALTA
2493
DELISTED
Altabancorp
ALTA
| $1.62M | ﹤0.01% |
57,391
-2,732
| -5% | -$77.6K |
|
2494
SI-BONE Inc
SIBN
$834M
| $1.62M | ﹤0.01% |
91,702
+25,576
| +39% | +$490K |
|
2495
Hawkins
HWKN
$2.71B
| $1.62M | ﹤0.01% |
76,036
-4,110
| -5% | -$90.1K |
|
|
MOFG
2496
DELISTED
MidWestOne Financial Group
MOFG
| $1.61M | ﹤0.01% |
52,851
+4,222
| +9% | +$124K |
|
|
MHI
2497
DELISTED
Pioneer Municipal High Income Fund
MHI
| $1.61M | ﹤0.01% |
129,314
| – | – |
|
|
OLBK
2498
DELISTED
Old Line Bancshares, Inc.
OLBK
| $1.61M | ﹤0.01% |
55,481
-292
| -0.5% | -$7.96K |
|
2499
Minerva Neurosciences
NERV
$199M
| $1.6M | ﹤0.01% |
25,876
+825
| +3% | +$46.7K |
|
|
HOME
2500
DELISTED
At Home Group Inc.
HOME
| $1.6M | ﹤0.01% |
166,643
+8,979
| +6% | +$61.3K |
|
Similar funds
VFT
Nuveen's Q3 2019 Portfolio in Review
As of Q3 2019, Nuveen held 3,301 positions worth $247B, down 2.7% from $254B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Nuveen withdrew a net $7.92B in Q3 2019, closing 86 positions and reducing 1,530 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in Medallia, Inc. worth $97.7M.
- Nuveen's largest Q3 2019 buy was Medallia, Inc.: 3,562,327 shares worth $97.7M.
- Nuveen added most to Fidelity National Information Services in Q3 2019, an estimated $508M increase.
- Nuveen's biggest Q3 2019 reduction was Microsoft, cutting an estimated $408M.
- Nuveen fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2019, selling an estimated $1.13B.
- Nuveen's ten largest holdings make up 18% of its $247B portfolio in Q3 2019.
- Nuveen opened 48 new positions and closed 86 in Q3 2019.
- Nuveen's portfolio value fell 2.7% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2019, filed 14 Nov 2019.